<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

Anne Staylor

Former Senior Editor, Medtech Insight. +25 years in various leadership roles in business intelligence, marketing, communications, product management, and consulting for medical device industry, hospitals, physician groups, insurers. Registered nurse and former Director of Marketing for a national ambulatory surgery company.

Neuro Therapies

R&D Focus on Neuromodulation: Patents, Products & Predictions

Despite the continuing challenges posed by the pandemic, the MedTech industry presses on with product in...

Neuro Therapies

NANS 2021: An Interview with Boston Scientific's Nilesh Patel, MD

Nilesh Patel, MD, vice president of medical affairs for Boston Scientific, discusses the Company’s lates...

Neuro Therapies

NANS 2021: An Interview with Medtronic's Charlie Covert

Charlie Covert, Medtronic’s VP/GM of Pain Therapies, discusses the Company’s neuromodulation news at NAN...

Neuro Therapies

A Ray of Sunshine but Dark Clouds Ahead: Q320 SCS Market Recap

The US Spinal Cord Stimulation Market saw a ray of sunshine in Q320 as revenues recovered to almost pre-...

Neuro Therapies

Magstim: Opportunities in Transcranial Magnetic Stimulation: An Interview with Lothar Krinke

Magstim CEO Lothar Krinke, PhD discusses Magstim and opportunities in transcranial magnetic stimulation ...

Neuro Therapies

Medtronic DTM SCS: Using Basic Science to Orchestrate Pain Relief

Charlie Covert, VP/GM of Medtronic’s Pain Therapies business, discusses 12-month follow up data from the...

Neuro Therapies

COVID Clobbers Spinal Cord Stimulation Market in Q220

COVID-19 hit the SCS market hard in Q220 as shutdowns and widespread procedure cancellations led to a dr...

Neuro Therapies

Elevating Stroke Care: An Interview with Imperative Care's Fred Khosravi

With plans to become a stroke strategic, Imperative Care Chairman and CEO Fred Khosravi discusses elevat...

Neuro Therapies

Cerenovus: Becoming a Key Player in Stroke: An Interview with Mark Dickinson

Mark Dickinson, Worldwide President of Cerenovus, discusses the Company’s focus on patients, innovation ...

Neuro Therapies

Growth Strategies Amid COVID-19: An Interview with Abbott's Keith Boettiger

Keith Boettiger, Vice President, Neuromodulation, Abbott discusses COVID-19 and the Company’s strategies...

1
...
6 7 8
...
12